[HTML][HTML] Hypertension and COVID-19: current evidence and perspectives
Abstract Coronavirus disease 2019 (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a real challenge for health …
respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a real challenge for health …
[HTML][HTML] Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong
Prior research using electronic health records for Covid-19 vaccine safety monitoring
typically focuses on specific disease groups and excludes individuals with multimorbidity …
typically focuses on specific disease groups and excludes individuals with multimorbidity …
Age, multiple chronic conditions, and COVID-19: a literature review
M Tisminetzky, C Delude, T Hebert… - The Journals of …, 2022 - academic.oup.com
Background Various patient demographic and clinical characteristics have been associated
with poor outcomes for individuals with coronavirus disease 2019 (COVID-19). To describe …
with poor outcomes for individuals with coronavirus disease 2019 (COVID-19). To describe …
Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión-Liga Española para la Lucha contra …
M Gorostidi, T Gijón-Conde, A De la Sierra… - Hipertension y riesgo …, 2022 - Elsevier
La hipertensión arterial es el principal factor de riesgo de enfermedad y muerte en España.
El diagnóstico y el tratamiento de la hipertensión arterial constituyen objetivos básicos de …
El diagnóstico y el tratamiento de la hipertensión arterial constituyen objetivos básicos de …
[HTML][HTML] Effect of coronary artery disease on COVID-19—prognosis and risk assessment: a systematic review and meta-analysis
L Szarpak, M Mierzejewska, J Jurek, A Kochanowska… - Biology, 2022 - mdpi.com
Simple Summary As of October 2021, over 245 million people have been infected and
nearly 5 million have died due to COVID-19. Atherosclerosis is a lipid-driven chronic …
nearly 5 million have died due to COVID-19. Atherosclerosis is a lipid-driven chronic …
[HTML][HTML] Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Introduction The diagnosis of COVID-19 is normally based on the qualitative detection of
viral nucleic acid sequences. Properties of the host response are not measured but are key …
viral nucleic acid sequences. Properties of the host response are not measured but are key …
Association between anti-diabetic agents and clinical outcomes of COVID-19 in patients with diabetes: a systematic review and meta-analysis
T Han, S Ma, C Sun, H Zhang, G Qu, Y Chen… - Archives of medical …, 2022 - Elsevier
Background and Aims During the current Coronavirus Disease 2019 (COVID-19) pandemic,
patients with diabetes face disproportionately more. This study was performed to clarify anti …
patients with diabetes face disproportionately more. This study was performed to clarify anti …
The experiences of care home staff during the COVID-19 pandemic: A systematic review
KL Gray, H Birtles, K Reichelt, IA James - Aging & mental health, 2022 - Taylor & Francis
Objectives: To examine experiences of care home staff to better understand how to support
them during the ongoing pandemic and in the future. Method: A systematic review …
them during the ongoing pandemic and in the future. Method: A systematic review …
[HTML][HTML] Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19
M Bucholc, D Bradley, D Bennett, L Patterson… - Scientific reports, 2022 - nature.com
We investigated the association between a wide range of comorbidities and COVID-19 in-
hospital mortality and assessed the influence of multi morbidity on the risk of COVID-19 …
hospital mortality and assessed the influence of multi morbidity on the risk of COVID-19 …